No insider purchase over the last 90 days. The latest was filed 30 Dec 2025.
This page follows insider dealings at Afyren as filed with AMF, a company from the Chemicals & Materials sector. 4 insiders have disclosed 4 filings since 18 October 2025.
No insider sold shares on the market over the period. Instead, the filings list 2 purchases totalling €157k, made by 2 insiders. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. On the buying side, the filings list 1 board member and 1 chief executive among the declarants. At €101k, the purchase published on 30 December 2025 by Jérémy Pessiot is the largest of the period.
Compared with its exchange (316 companies, median 6 filings), a count of 4 filings is below the norm. The full history, which starts in 2022, counts 26 purchases against no sales.
Within a 30-day window, 1 purchase overlapped with buying by a second insider. Purchases made close together by different insiders form what is called a cluster. The latest purchase dates back some time: it was published 291 days ago, on 30 December 2025. Typically, a trade is published a median of 7 days after it takes place. The regulation allows three business days to notify a trade (MAR article 19).
Other companies in the same sector with recent insider buying flagged by our signals: Culp Inc. These figures are compiled from regulatory filings published by AMF. They describe what insiders did and are not a recommendation.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Afyren Strong Buy (bullish), based on 3 analysts. Average price target: €4.43.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 28 declarations
Afyren is a French greentech company focused on biosourced chemistry and biomass valorization through fermentation. Listed on Euronext Growth Paris since 2021 under ISIN FR0014005AC9 and ticker ALAFY, the company develops a proprietary industrial technology designed to produce renewable organic molecules that can replace petrochemical ingredients. Its positioning sits at the intersection of the circular economy, decarbonization and the transition toward lower-carbon industrial inputs.
Founded by teams with a background in science and industry, Afyren built its business model around a breakthrough process based on natural microorganisms. Using fermentation, it converts non-food biomass by-products into organic acids and other high-value molecules. The company emphasizes a zero-waste logic and a regenerative, green-chemistry approach. A key commercial advantage is that its solutions are designed to be plug-and-play for industrial customers, allowing them to adopt more sustainable ingredients without having to materially redesign their production processes.
Afyren’s first industrial asset, Afyren NEOXY, is a biorefinery located in the Grand Est region of France and primarily serves the European market. In 2025, the company took full control of this plant, an important milestone that strengthened its industrial and operational oversight. Beyond France, Afyren is also advancing an industrial project in Thailand with a major sugar industry player and is expanding its commercial footprint in the Americas through existing distribution agreements.
The company targets several strategic end markets: human and animal nutrition, flavors and fragrances, life sciences, materials science, lubricants and technical fluids. This diversification broadens its addressable market and supports the relevance of its platform technology across multiple downstream industries. At the end of 2025, Afyren employed 140 people across Lyon, Clermont-Ferrand and Carling Saint-Avold, and it dedicated about 20% of its annual budget to R&D, underlining a strongly innovative and capital-intensive profile. Overall, Afyren is emerging as a notable French player in sustainable chemistry, combining proprietary technology, industrial scale-up and international growth ambitions.
Purchases our model currently ranks for the recommendations list.
All recommendations